Cargando…
Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy
BACKGROUND: The current study aimed to evaluate the serum pretreatment lactate dehydrogenase (LDH) and overall survival (OS) in small cell lung cancer (SCLC) patients who received first‐line platinum‐containing chemotherapy. METHODS: A total of 234 SCLC patients, who received first‐line platinum‐bas...
Autores principales: | He, Man, Chi, Xiaorui, Shi, Xinyan, Sun, Yang, Yang, Xue, Wang, Leirong, Wang, Bingrui, Li, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636211/ https://www.ncbi.nlm.nih.gov/pubmed/34725930 http://dx.doi.org/10.1111/1759-7714.13581 |
Ejemplares similares
-
The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Liu, Xiaofan, et al.
Publicado: (2017) -
Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis
por: Zhang, Jiao, et al.
Publicado: (2015) -
Regulating tumor glycometabolism and the immune microenvironment by inhibiting lactate dehydrogenase with platinum(iv) complexes
por: Jin, Suxing, et al.
Publicado: (2023) -
The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Li, Qi, et al.
Publicado: (2023) -
Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients: A meta-analysis of 18 observational studies
por: Gan, Jianxin, et al.
Publicado: (2018)